Franklin Resources Inc Abb Vie Inc. Transaction History

Franklin Resources Inc

$304 Billion
Q1 2024

A detailed history of Franklin Resources Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 11,146,347 shares of ABBV stock, worth $1.8 Billion. This represents 0.67% of its overall portfolio holdings.

Number of Shares

11,146,347

Previous 7,570,685 47.23%

Holding current value

$1.8 Billion

Previous $1.17 Billion 73.01%

% of portfolio

0.67%

Previous 0.57%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $571 Million - $651 Million	3,575,662 Added 47.23%	11,146,347 $2.03 Billion
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $46.6 Million - $52.5 Million	338,789 Added 4.68%	7,570,685 $1.17 Billion
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $14.8 Million - $17.1 Million	110,691 Added 1.55%	7,231,896 $1.08 Billion
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $127 Million - $159 Million	-961,754 Reduced 11.9%	7,121,205 $959 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $396 Million - $456 Million	-2,736,893 Reduced 25.3%	8,082,959 $1.29 Billion

Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $139 Million - $166 Million	-1,003,268 Reduced 8.49%	10,819,852 $1.75 Billion
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $134 Million - $154 Million	-998,615 Reduced 7.79%	11,823,120 $1.59 Billion
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $185 Million - $236 Million	-1,346,574 Reduced 9.5%	12,821,735 $1.96 Billion
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $746 Million - $925 Million	-5,648,748 Reduced 28.5%	14,168,309 $2.3 Billion
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $349 Million - $442 Million	3,249,849 Added 19.62%	19,817,057 $2.68 Billion
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $8.1 Million - $9.2 Million	-76,159 Reduced 0.46%	16,567,208 $1.79 Billion
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $775 Million - $864 Million	7,370,931 Added 79.49%	16,643,367 $1.87 Billion
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $462 Million - $509 Million	4,517,035 Added 94.99%	9,272,436 $1 Billion
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $95.9 Million - $130 Million	-1,191,805 Reduced 20.04%	4,755,401 $510 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $77 Million - $90.3 Million	-895,784 Reduced 13.09%	5,947,206 $521 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $205 Million - $274 Million	2,789,463 Added 68.82%	6,842,990 $669 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $17,673 - $26,794	274 Added 0.01%	4,053,527 $309 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $5.58 Million - $6.98 Million	77,314 Added 1.94%	4,053,253 $359 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $149 Million - $179 Million	-2,362,468 Reduced 37.27%	3,975,939 $301 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $135 Million - $173 Million	2,060,033 Added 48.15%	6,338,407 $461 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $472,173 - $555,725	6,121 Added 0.14%	4,278,374 $345 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $9.78 Million - $12.1 Million	125,596 Added 3.03%	4,272,253 $394 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $24.4 Million - $27.2 Million	-274,846 Reduced 6.22%	4,146,657 $392 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $5.55 Million - $6.57 Million	61,838 Added 1.42%	4,421,503 $410 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $31.3 Million - $42 Million	340,709 Added 8.48%	4,359,665 $413 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $15.3 Million - $16.8 Million	-170,964 Reduced 4.08%	4,018,956 $389 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $293 Million - $374 Million	4,189,920	4,189,920 $372 Million

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Abb Vie Inc. Transaction History